S&P 500   5,058.25 (+0.14%)
DOW   37,828.84 (+0.08%)
QQQ   430.36 (-0.17%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,058.25 (+0.14%)
DOW   37,828.84 (+0.08%)
QQQ   430.36 (-0.17%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,058.25 (+0.14%)
DOW   37,828.84 (+0.08%)
QQQ   430.36 (-0.17%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,058.25 (+0.14%)
DOW   37,828.84 (+0.08%)
QQQ   430.36 (-0.17%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
NYSE:AGL

agilon health (AGL) Stock Price, News & Analysis

$4.48
+0.02 (+0.45%)
(As of 04/16/2024 ET)
Today's Range
$4.45
$4.79
50-Day Range
$4.46
$7.45
52-Week Range
$4.44
$28.99
Volume
5.84 million shs
Average Volume
4.30 million shs
Market Capitalization
$1.83 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.73

agilon health MarketRank™ Stock Analysis

Analyst Rating
Hold
2.19 Rating Score
Upside/​Downside
117.4% Upside
$9.73 Price Target
Short Interest
Bearish
15.54% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.09mentions of agilon health in the last 14 days
Based on 16 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.35) to ($0.19) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.21 out of 5 stars

Medical Sector

794th out of 930 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

8th out of 8 stocks

AGL stock logo

About agilon health Stock (NYSE:AGL)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

AGL Stock Price History

AGL Stock News Headlines

This consistently signaled gains of 453%... 610%... and even 1036%...
It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.
This consistently signaled gains of 453%... 610%... and even 1036%...
It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.
See More Headlines
Receive AGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for agilon health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Today
4/17/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Fax
N/A
Employees
1,117
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$9.73
High Stock Price Target
$18.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+117.4%
Consensus Rating
Hold
Rating Score (0-4)
2.19
Research Coverage
16 Analysts

Profitability

Net Income
$-262,600,000.00
Pretax Margin
-4.51%

Debt

Sales & Book Value

Annual Sales
$4.32 billion
Book Value
$1.63 per share

Miscellaneous

Free Float
396,027,000
Market Cap
$1.83 billion
Optionable
Not Optionable
Beta
0.49
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Steven Jackson Sell (Age 58)
    President, CEO & Director
    Comp: $1.29M
  • Mr. Timothy S. Bensley (Age 63)
    Chief Financial Officer
    Comp: $831.31k
  • Mr. Girish Venkatachaliah (Age 50)
    Chief Technology Officer
    Comp: $655.04k
  • Mr. Ben Shaker (Age 41)
    Chief Markets Officer
    Comp: $715.5k
  • Mr. Veeral  DesaiMr. Veeral Desai (Age 43)
    Chief Strategy & Development Officer
    Comp: $667.58k
  • Mr. Timothy Gertsch (Age 38)
    VP, Controller & Chief Accounting Officer
  • Mr. Matthew Dale Gillmor CFA
    Vice President of Investor Relations
  • Ms. Denise Zamore
    Chief Legal Officer & Secretary
  • Ms. Claire Mulhearn
    Chief Communications & Public Affairs Officer
  • Mr. Mat Varghese
    Chief People Officer

AGL Stock Analysis - Frequently Asked Questions

Should I buy or sell agilon health stock right now?

16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for agilon health in the last twelve months. There are currently 1 sell rating, 11 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AGL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AGL, but not buy additional shares or sell existing shares.
View AGL analyst ratings
or view top-rated stocks.

What is agilon health's stock price target for 2024?

16 Wall Street research analysts have issued 12 month price objectives for agilon health's stock. Their AGL share price targets range from $5.00 to $18.00. On average, they predict the company's share price to reach $9.73 in the next year. This suggests a possible upside of 117.4% from the stock's current price.
View analysts price targets for AGL
or view top-rated stocks among Wall Street analysts.

How have AGL shares performed in 2024?

agilon health's stock was trading at $12.55 at the start of the year. Since then, AGL stock has decreased by 64.3% and is now trading at $4.4750.
View the best growth stocks for 2024 here
.

When is agilon health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our AGL earnings forecast
.

How were agilon health's earnings last quarter?

agilon health, inc. (NYSE:AGL) released its earnings results on Tuesday, February, 27th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by $0.13. The firm earned $1.06 billion during the quarter, compared to the consensus estimate of $1.02 billion. agilon health had a negative net margin of 5.76% and a negative trailing twelve-month return on equity of 21.74%. agilon health's revenue was up 71.8% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.14) EPS.

What guidance has agilon health issued on next quarter's earnings?

agilon health updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $6.4 billion-$6.5 billion, compared to the consensus revenue estimate of $6.3 billion.

When did agilon health IPO?

agilon health (AGL) raised $1 billion in an initial public offering on Thursday, April 15th 2021. The company issued 46,600,000 shares at a price of $20.00-$23.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank Securities and Wells Fargo Securities acted as the underwriters for the IPO and William Blair, Truist Securities and Nomura were co-managers.

Who are agilon health's major shareholders?

agilon health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Renaissance Capital LLC (0.05%) and Counterpoint Mutual Funds LLC (0.02%). Insiders that own company stock include Benjamin Kornitzer, Benjamin Shaker, Cd&R Investment Associates Ix,, Clay Richards, Glenn Sobotka, Jeffrey A Schwaneke, Joan Danieley, John William Wulf, Michael L Smith, Steven Sell, Theodore Halkias, Timothy Gertsch and Veeral Desai.
View institutional ownership trends
.

How do I buy shares of agilon health?

Shares of AGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:AGL) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners